CEO Greeting
-
Myoung-Hwan Park, Ph.D.
CEO
-
Our primary mission is to develop a micro-bubble-based and ultrasound-guided drug delivery platform to provide effective brain tumor treatment by containing high-concentration of drugs optimized for patients.
Another mission is to develop and produce new functional cosmetics using our customized nanobubble technology.
Together with our executives and employees, NtoB will continue to improve human health and quality of life through bubble technology.
We will do our best to become a leader in a new medical paradigm of “Nano to Bubbles”.With Many Thanks